As [Nal(2’)4]CJ-15,208 displayed bifunctional MOR agonist/DOR antagonist activity, it was then assessed for potential liabilities produced by standard MOR opioid agonists, specifically antinociceptive tolerance, respiratory depression, hyperlocomotion, and conditioned place preference. Here, OPRM1 is linked to Respiratory insufficiency due to muscle weakness.